Trademark: 79266020
Word
SATIVEX
Status
Dead
Status Code
603
Status Date
Monday, January 23, 2023
Serial Number
79266020
Mark Type
4
Filing Date
Wednesday, July 17, 2019
Abandoned Date
Monday, January 23, 2023

Trademark Owner History
GW Research Limited - 1st New Owner Before Publication
GW Pharma Limited - Original Applicant

Classifications
5 Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes

Trademark Events
Jul 28, 2020
Assigned To Examiner
Aug 22, 2019
Sn Assigned For Sect 66a Subseq Desig From Ib
Aug 26, 2019
Limitation From Original Application Entered
Sep 4, 2019
New Application Office Supplied Data Entered
Sep 10, 2019
Application Filing Receipt Mailed
Sep 21, 2019
Assigned To Examiner
Jul 30, 2020
Non-Final Action Written
Feb 13, 2021
Notification Of Possible Opposition - Processed By Ib
Jul 31, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Aug 12, 2020
Non-Final Action (Ib Refusal) Withdrawn For Review
Aug 14, 2020
Non-Final Action Written
Aug 15, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Sep 9, 2020
Refusal Processed By Mpu
Sep 10, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 26, 2020
Refusal Processed By Ib
Jan 27, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 27, 2021
Notification Of Possible Opposition Sent To Ib
May 3, 2021
Notification Of Final Refusal Emailed
Mar 8, 2021
Teas Response To Office Action Received
Mar 8, 2021
Correspondence Received In Law Office
Mar 9, 2021
Teas/Email Correspondence Entered
May 3, 2021
Final Refusal Written
May 3, 2021
Final Refusal E-Mailed
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 3, 2021
Teas Request For Reconsideration Received
Nov 3, 2021
Exparte Appeal Received At Ttab
Nov 3, 2021
Jurisdiction Restored To Examining Attorney
Nov 3, 2021
Ex Parte Appeal-Instituted
Nov 8, 2021
Assigned To Lie
Nov 9, 2021
Teas/Email Correspondence Entered
Nov 9, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 9, 2021
Correspondence Received In Law Office
Nov 20, 2021
New Representative At Ib Received
Jan 3, 2022
Non-Final Action Written
Jan 3, 2022
Non-Final Action E-Mailed
Jan 3, 2022
Notification Of Non-Final Action E-Mailed
Jul 5, 2022
Teas Response To Office Action Received
Jul 5, 2022
Correspondence Received In Law Office
Aug 17, 2022
Notification Of Subsequent Final Emailed
Jul 6, 2022
Teas/Email Correspondence Entered
Aug 17, 2022
Subsequent Final Refusal Written
Aug 17, 2022
Subsequent Final Emailed
Jan 5, 2023
International Registration Renewed
Dec 9, 2022
Exparte Appeal Dismissed - Failure To File Brief
Mar 11, 2024
Final Decision Transaction Processed By Ib
Jan 23, 2023
Abandonment - After Ex Parte Appeal
Feb 10, 2023
Abandonment Notice Mailed - After Ex Parte Appeal
Jan 23, 2023
Exparte Appeal Terminated
Feb 10, 2023
Abandonment Notice Mailed - After Ex Parte Appeal
Feb 10, 2024
Final Disposition Notice Created, To Be Sent To Ib
Feb 12, 2024
Final Disposition Notice Sent To Ib
May 31, 2024
Change Of Owner Received From Ib

Trademark Alertz updated from USPTO on 2030-01-24